Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE

Accepted 2025-11-04 00:00:00 ET · period of report 2025-10-31 · accession 0001971702-25-000009 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2025-11-04	2025-10-31	CLOV	Wai Conrad	CEO, Counterpart Health	F - Tax	$3.53	-124.4K	1.18M	-10%	-$439.1K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2025-10-31	F	D	27,930	$3.53	1,150,085	D	—	—	(F2) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on October 31, 2025, of the final 12.5% of RSUs granted to the Reporting Person on October 31, 2025.
2	Common	Class A Common Stock	2025-10-31	F	D	96,448	$3.53	1,178,015	D	—	—	(F1) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of the final 50% of the number of earned performance-based restricted stock units (RSU), as described herein. Each RSU represented a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on October 31, 2023. One-half of the number of earned restricted stock units vested and were settled on September 13, 2024, and the remaining one-half of the restricted stock units vested on October 31, 2025.